Common side effects include: Constipation Decreased appetite Diarrhea Nausea Vomiting Researchers reported that these side effects were usually mild to moderate and most commonly occurred during the dose-escalation phase of treatment
Effects of GLP-1RAs on Specific Inflammatory Skin Diseases While research is still ongoing, early indications are that GLP-1s may offer benefits for inflammatory skin diseases, including: Psoriasis immune dysregulation related to T cells and cytokines leads to systemic inflammation, skin discoloration, and thickening plaques
The SURMOUNT and SURPASS trials showed tirzepatide may produce greater weight loss than semaglutide at comparable doses
The theoretical advantage is smoother blood levels with less peak-to-trough variation, which may reduce the intensity of side effects, particularly nausea and appetite fluctuation
Segundo Miranda, passar pela aprovao das agncias reguladoras no significa que no existam efeitos adversos que devem ser monitorados e acompanhados, mas que assegura que o medicamento foi avaliado para a segurana em seres humanos